aztreonam has been researched along with Bronchial Diseases in 1 studies
Aztreonam: A monocyclic beta-lactam antibiotic originally isolated from Chromobacterium violaceum. It is resistant to beta-lactamases and is used in gram-negative infections, especially of the meninges, bladder, and kidneys. It may cause a superinfection with gram-positive organisms.
aztreonam : A synthetic monocyclic beta-lactam antibiotic (monobactam), used primarily to treat infections caused by Gram-negative bacteria. It inhibits mucopeptide synthesis in the bacterial cell wall, thereby blocking peptidoglycan crosslinking.
Bronchial Diseases: Diseases involving the BRONCHI.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Aquino, G | 1 |
| Barbera, S | 1 |
| Romano, F | 1 |
| Zottola, V | 1 |
1 other study available for aztreonam and Bronchial Diseases
| Article | Year |
|---|---|
[Use of aztreonam in the treatment of acute and flare-ups of chronic infectious bronchopneumopathies].
Topics: Adult; Aged; Aged, 80 and over; Aztreonam; Bacterial Infections; Bronchial Diseases; Bronchopneumoni | 1988 |